# Nelnet Inc: financial statements, quarterly

NNI · NYSE · CIK 1258602 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nni.md) · [Financials](/companies/nni/financials.md) · [Filings](/companies/nni/filings.md) · [Insiders](/companies/nni/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nni/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Cost of revenue | $m | [51.5](/filings/0001258602-24-000058.md) | [62.8 d](/filings/0001258602-26-000014.md) | [62.8](/filings/0001258602-25-000035.md) | [48.5](/filings/0001258602-25-000050.md) | [72.3](/filings/0001258602-25-000063.md) | [68.7 d](/filings/0001258602-26-000014.md) | [57.5](/filings/0001258602-26-000033.md) | [55.7](/filings/0001258602-26-000042.md) | [60.0](/filings/0001258602-25-000063.md) | [53.0 d](/filings/0001258602-26-000014.md) | [52.0](/filings/0001258602-26-000033.md) | [41.3](/filings/0001258602-26-000042.md) |
| Interest expense | $m | [207](/filings/0001258602-23-000073.md) | [205 d](/filings/0001258602-24-000024.md) | [195](/filings/0001258602-24-000039.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [10.5](/filings/0001258602-24-000058.md) | [(9.4) d](/filings/0001258602-26-000014.md) | [23.2](/filings/0001258602-25-000035.md) | [14.8](/filings/0001258602-25-000050.md) | [(0.3)](/filings/0001258602-25-000063.md) | [15.0 d](/filings/0001258602-26-000014.md) | [25.0](/filings/0001258602-26-000033.md) | [59.5](/filings/0001258602-26-000042.md) | [35.8](/filings/0001258602-25-000063.md) | [7.7 d](/filings/0001258602-26-000014.md) | [20.1](/filings/0001258602-26-000033.md) | [19.9](/filings/0001258602-26-000042.md) |
| Net income | $m | [44.4](/filings/0001258602-24-000058.md) | [(7.9) d](/filings/0001258602-26-000014.md) | [73.4](/filings/0001258602-25-000035.md) | [45.1](/filings/0001258602-25-000050.md) | [2.4](/filings/0001258602-25-000063.md) | [63.2 d](/filings/0001258602-26-000014.md) | [82.6](/filings/0001258602-26-000033.md) | [181](/filings/0001258602-26-000042.md) | [107](/filings/0001258602-25-000063.md) | [57.8 d](/filings/0001258602-26-000014.md) | [71.1](/filings/0001258602-26-000033.md) | [66.7](/filings/0001258602-26-000042.md) |
| Diluted EPS | $ per share | [1.18](/filings/0001258602-24-000058.md) | not reported | [1.98](/filings/0001258602-25-000035.md) | [1.23](/filings/0001258602-25-000050.md) | [0.07](/filings/0001258602-25-000063.md) | not reported | [2.26](/filings/0001258602-26-000033.md) | [4.97](/filings/0001258602-26-000042.md) | [2.94](/filings/0001258602-25-000063.md) | not reported | [1.97](/filings/0001258602-26-000033.md) | [1.85](/filings/0001258602-26-000042.md) |
| Basic EPS | $ per share | [1.18](/filings/0001258602-24-000058.md) | not reported | [1.98](/filings/0001258602-25-000035.md) | [1.23](/filings/0001258602-25-000050.md) | [0.07](/filings/0001258602-25-000063.md) | not reported | [2.26](/filings/0001258602-26-000033.md) | [4.97](/filings/0001258602-26-000042.md) | [2.94](/filings/0001258602-25-000063.md) | not reported | [1.97](/filings/0001258602-26-000033.md) | [1.85](/filings/0001258602-26-000042.md) |

- Revenue: not reported
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001258602-24-000058.md) | [0.2](/filings/0001258602-26-000014.md) | [0.2](/filings/0001258602-25-000035.md) | [0.1](/filings/0001258602-25-000050.md) | [0.2](/filings/0001258602-25-000063.md) | [0.2](/filings/0001258602-26-000042.md) | [0.2](/filings/0001258602-26-000033.md) | [0.2](/filings/0001258602-26-000042.md) | [0.2](/filings/0001258602-25-000063.md) | [0.3](/filings/0001258602-26-000042.md) | [0.2](/filings/0001258602-26-000033.md) | [0.2](/filings/0001258602-26-000042.md) |
| Total assets | $bn | [17.2](/filings/0001258602-24-000058.md) | [16.7](/filings/0001258602-26-000014.md) | [15.4](/filings/0001258602-25-000035.md) | [14.5](/filings/0001258602-25-000050.md) | [14.1](/filings/0001258602-25-000063.md) | [13.8](/filings/0001258602-26-000014.md) | [14.2](/filings/0001258602-26-000033.md) | [13.7](/filings/0001258602-26-000042.md) | [13.9](/filings/0001258602-25-000063.md) | [14.1](/filings/0001258602-26-000042.md) | [14.2](/filings/0001258602-26-000033.md) | [14.3](/filings/0001258602-26-000042.md) |
| Total liabilities | $bn | [14.0](/filings/0001258602-23-000073.md) | [13.5](/filings/0001258602-25-000014.md) | [12.1](/filings/0001258602-24-000039.md) | [11.3](/filings/0001258602-24-000050.md) | [10.9](/filings/0001258602-24-000058.md) | [10.5](/filings/0001258602-26-000014.md) | [10.8](/filings/0001258602-25-000035.md) | [10.2](/filings/0001258602-25-000050.md) | [10.3](/filings/0001258602-25-000063.md) | [10.5](/filings/0001258602-26-000042.md) | [10.6](/filings/0001258602-26-000033.md) | [10.6](/filings/0001258602-26-000042.md) |
| Long-term debt | $bn | [12.4](/filings/0001258602-23-000073.md) | [11.8](/filings/0001258602-25-000014.md) | [10.6](/filings/0001258602-24-000039.md) | [9.6](/filings/0001258602-24-000050.md) | [8.9](/filings/0001258602-24-000058.md) | [8.3](/filings/0001258602-26-000014.md) | [8.7](/filings/0001258602-25-000035.md) | [7.9](/filings/0001258602-25-000050.md) | [7.8](/filings/0001258602-25-000063.md) | [7.8](/filings/0001258602-26-000042.md) | [7.7](/filings/0001258602-26-000033.md) | [7.0](/filings/0001258602-26-000042.md) |
| Shareholders' equity | $bn | [3.3](/filings/0001258602-23-000073.md) | [3.3](/filings/0001258602-25-000014.md) | [3.3](/filings/0001258602-24-000039.md) | [3.3](/filings/0001258602-24-000050.md) | [3.3](/filings/0001258602-24-000058.md) | [3.3](/filings/0001258602-26-000014.md) | [3.4](/filings/0001258602-25-000035.md) | [3.6](/filings/0001258602-25-000050.md) | [3.7](/filings/0001258602-25-000063.md) | [3.7](/filings/0001258602-26-000042.md) | [3.7](/filings/0001258602-26-000033.md) | [3.8](/filings/0001258602-26-000042.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [154 d](/filings/0001258602-24-000058.md) | [79.5 d](/filings/0001258602-26-000014.md) | [212](/filings/0001258602-25-000035.md) | [134 d](/filings/0001258602-25-000050.md) | [137 d](/filings/0001258602-25-000063.md) | [181 d](/filings/0001258602-26-000014.md) | [91.2](/filings/0001258602-26-000033.md) | [81.8 d](/filings/0001258602-26-000042.md) | [112 d](/filings/0001258602-25-000063.md) | [138 d](/filings/0001258602-26-000014.md) | [73.1](/filings/0001258602-26-000033.md) | [77.9 d](/filings/0001258602-26-000042.md) |
| Capital expenditure | $m | [15.4 d](/filings/0001258602-24-000058.md) | [21.4 d](/filings/0001258602-26-000014.md) | [23.2](/filings/0001258602-25-000035.md) | [10.6 d](/filings/0001258602-25-000050.md) | [4.4 d](/filings/0001258602-25-000063.md) | [(17.4) d](/filings/0001258602-26-000014.md) | [3.4](/filings/0001258602-26-000033.md) | [3.7 d](/filings/0001258602-26-000042.md) | [11.7 d](/filings/0001258602-25-000063.md) | [7.5 d](/filings/0001258602-26-000014.md) | [11.6](/filings/0001258602-26-000033.md) | [6.3 d](/filings/0001258602-26-000042.md) |
| Dividends paid | $m | [9.7 d](/filings/0001258602-24-000058.md) | [10.4 d](/filings/0001258602-26-000014.md) | [10.4](/filings/0001258602-25-000035.md) | [10.2 d](/filings/0001258602-25-000050.md) | [10.1 d](/filings/0001258602-25-000063.md) | [10.2 d](/filings/0001258602-26-000014.md) | [10.2](/filings/0001258602-26-000033.md) | [10.2 d](/filings/0001258602-26-000042.md) | [10.8 d](/filings/0001258602-25-000063.md) | [11.8 d](/filings/0001258602-26-000014.md) | [11.8](/filings/0001258602-26-000033.md) | [11.8 d](/filings/0001258602-26-000042.md) |
| Share repurchases | $m | [0.5 d](/filings/0001258602-24-000058.md) | [23.7 d](/filings/0001258602-26-000014.md) | [35.5](/filings/0001258602-25-000035.md) | [46.8 d](/filings/0001258602-25-000050.md) | [0.6 d](/filings/0001258602-25-000063.md) | [0.4 d](/filings/0001258602-26-000014.md) | [4.5](/filings/0001258602-26-000033.md) | [21.4 d](/filings/0001258602-26-000042.md) | [27.3 d](/filings/0001258602-25-000063.md) | [16.3 d](/filings/0001258602-26-000014.md) | [16.3](/filings/0001258602-26-000033.md) | [24.4 d](/filings/0001258602-26-000042.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [37.4](/filings/0001258602-23-000073.md) | [37.3](/filings/0001258602-24-000039.md) | [37.5](/filings/0001258602-24-000050.md) | [37.5](/filings/0001258602-24-000058.md) | [37.2](/filings/0001258602-25-000035.md) | [36.5](/filings/0001258602-25-000050.md) | [36.4](/filings/0001258602-25-000063.md) | [36.5](/filings/0001258602-26-000033.md) | [36.5](/filings/0001258602-26-000042.md) | [36.3](/filings/0001258602-25-000063.md) | [36.1](/filings/0001258602-26-000033.md) | [36.0](/filings/0001258602-26-000042.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.